Affordable Access

Transdermal selegiline: targeted effects on monoamine oxidases in the brain.

Authors
Type
Published Article
Journal
Biological Psychiatry
0006-3223
Publisher
Elsevier
Publication Date
Volume
54
Issue
10
Pages
1099–1104
Identifiers
PMID: 14625153
Source
Medline
License
Unknown

Abstract

Results suggest that transdermal selegiline preferentially inhibits MAO-A in brain relative to the gastrointestinal system. As a consequence, transdermal selegiline should be devoid of the potential to cause a hypertensive reaction after the ingestion of tyramine-containing compounds.

Statistics

Seen <100 times